It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 1994.
1994 | Navi Mumbai, Maharashtra, India | ActiveStanpack Pharma Private Limited, a active private limited company, was established on 22 March 1994 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239MH1994PTC077217. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Its leadership includes Archana Sanjay Prasad (Director), Sanjay Kumar Prasad (Managing Director). Past directors included Rajiv Suresh Priyadarshi. It holds ₹1.84 Cr open charges and ₹23.88 Cr settled loans. Its latest AGM occurred on 30 November 2024, with the balance sheet filed on 31 March 2024. It is based at 201, Plot No. 100, Sunrise Arcade, Sector 16 Kopar Khairane Navi Mumbai, Navi Mumbai, Maharashtra, 400709.
U24239MH1994PTC077217
077217
22 March 1994
₹4.00 M
₹4.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Stanpack Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Sanjay Prasad | Director | 01 Apr 2009 | Current |
| Sanjay Kumar Prasad | Managing Director | 22 Mar 1994 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 May 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stanpack Pharma Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 101% increase. The company also saw a substantial improvement in profitability, with a 107.58% increase in profit. The company's net worth moved up by a moderate rise of 0.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Stanpack Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹18,400,000.00
₹238,819,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2008 | Tifac | ₹1.84 Cr | Open |
| 14 Mar 2011 | Union Bank Of India | ₹3.85 Cr | Satisfied |
| 04 Jun 2007 | Union Bank Of India | ₹1.00 Cr | Satisfied |
| 04 Jun 2007 | Union Bank Of India | ₹2.00 M | Satisfied |
| 04 Jun 2007 | Union Bank Of India | ₹7.96 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Stanpack Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Stanpack Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanpack Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Stanpack Pharma Private Limited last Annual general meeting of members was held on 30 Nov 2024 as per latest MCA records. was documented.
The activity Stanpack Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge registered on 14 Mar 2011 via Charge ID 10276414 with Union Bank Of India was fully satisfied on 13 Jun 2015. was completed.
Progress on A charge registered on 04 Jun 2007 via Charge ID 10059539 with Union Bank Of India was fully satisfied on 13 Jun 2015. was documented.
The activity A charge registered on 04 Jun 2007 via Charge ID 10063347 with Union Bank Of India was fully satisfied on 13 Jun 2015. was completed.
A charge registered on 04 Jun 2007 via Charge ID 10063288 with Union Bank Of India was fully satisfied on 13 Jun 2015. was recorded as a recent event.
The CIN of Stanpack Pharma Private Limited is U24239MH1994PTC077217.
Stanpack Pharma Private Limited is headquartered at 201, Plot No. 100, Sunrise Arcade, Sector 16 Kopar Khairane Navi Mumbai, Navi Mumbai, Maharashtra, 400709.
Stanpack Pharma Private Limited was incorporated on 22 March 1994.
The current directors of Stanpack Pharma Private Limited are
The primary industry of Stanpack Pharma Private Limited is Pharma.
Stanpack Pharma Private Limited is unlisted.
The authorized capital of Stanpack Pharma Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Stanpack Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX